Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker AMGN
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | Rachna Khosla SVP, Business Development | AMGN Amgen Inc. | Sale | 1,252 | $416.43 | $521.4K Sale | Form 4 ↗ |
| Aug 11, 2026 | Rachna Khosla SVP, Business Development | AMGN Amgen Inc. | Sale | 2,000 | $412.57 | $825.1K Sale | Form 4 ↗ |
| Aug 6, 2026 | Derek Miller SVP, Human Resources | AMGN Amgen Inc. | Sale | 1,821 | $402.54 | $733.0K Sale | Form 4 ↗ |
| Aug 6, 2026 | Derek Miller SVP, Human Resources | AMGN Amgen Inc. | Sale | 2,069 | $402.54 | $832.9K Sale | Form 4 ↗ |
| Aug 6, 2026 | Nancy A. Grygiel SVP & CCO | AMGN Amgen Inc. | Sale | 1,000 | $402.16 | $402.2K Sale | Form 4 ↗ |
| Aug 6, 2026 | Nancy A. Grygiel SVP & CCO | AMGN Amgen Inc. | Sale | 1,970 | $402.16 | $792.3K Sale | Form 4 ↗ |
| May 4, 2026 | Nancy A. Grygiel SVP & CCO | AMGN Amgen Inc. | Sale | 1,237 | $323.73 | $400.5K Sale | Form 4 ↗ |
| Feb 26, 2026 | Esteban Santos EVP, Operations | AMGN Amgen Inc. | Sale | 24,291 | $379.12 | $9.2M Sale | Form 4 ↗ |
| Feb 26, 2026 | Esteban Santos EVP, Operations | AMGN Amgen Inc. | Sale | 30,501 | $379.12 | $11.6M Sale | Form 4 ↗ |
| Feb 19, 2026 | Matthew C. Busch VP, Finance & CAO | AMGN Amgen Inc. | Sale | 1,000 | $375.79 | $375.8K Sale | Form 4 ↗ |
| Nov 20, 2025 | Nancy A. Grygiel SVP & CCO | AMGN Amgen Inc. | Sale | 1,639 | $337.26 | $552.8K Sale | Form 4 ↗ |
| Nov 20, 2025 | Nancy A. Grygiel SVP & CCO | AMGN Amgen Inc. | Sale | 1,500 | $337.26 | $505.9K Sale | Form 4 ↗ |
| Nov 12, 2025 | Rachna Khosla SVP, Business Development | AMGN Amgen Inc. | Sale | 890 | $336.24 | $299.3K Sale | Form 4 ↗ |
| Nov 12, 2025 | Murdo Gordon EVP, Global Commercial Ops | AMGN Amgen Inc. | Sale | 6,879 | $336.83 | $2.3M Sale | Form 4 ↗ |
| Aug 20, 2025 | Nancy A. Grygiel SVP & CCO | AMGN Amgen Inc. | Sale | 1,267 | $296.99 | $376.3K Sale | Form 4 ↗ |
| Jun 5, 2025 | Rachna Khosla SVP, Business Development | AMGN Amgen Inc. | Sale | 1,500 | $289.68 | $434.5K Sale | Form 4 ↗ |
| May 2, 2025 | Matthew C. Busch VP, Finance & CAO | AMGN Amgen Inc. | Sale | 1,000 | $279.69 | $279.7K Sale | Form 4 ↗ |
| Feb 21, 2025 | David M. Reese EVP & Chief Technology Officer | AMGN Amgen Inc. | Sale | 25,225 | $304.44 | $7.7M Sale | Form 4 ↗ |
| Feb 19, 2025 | Esteban Santos EVP, Operations | AMGN Amgen Inc. | Sale | 8,711 | $292.84 | $2.6M Sale | Form 4 ↗ |
| Feb 19, 2025 | David M. Reese EVP & Chief Technology Officer | AMGN Amgen Inc. | Sale | 8,711 | $293.22 | $2.6M Sale | Form 4 ↗ |
| Feb 19, 2025 | Derek Miller SVP, Human Resources | AMGN Amgen Inc. | Sale | 1,524 | $293.74 | $447.7K Sale | Form 4 ↗ |
| Feb 18, 2025 | Derek Miller SVP, Human Resources | AMGN Amgen Inc. | Sale | 500 | $292.56 | $146.3K Sale | Form 4 ↗ |
| Feb 11, 2025 | Murdo Gordon EVP, Global Commercial Ops | AMGN Amgen Inc. | Sale | 8,771 | $294.79 | $2.6M Sale | Form 4 ↗ |
| Feb 7, 2025 | Jonathan P. Graham EVP & Gen. Counsel & Secy. | AMGN Amgen Inc. | Sale | 25,045 | $293.12 | $7.3M Sale | Form 4 ↗ |
| Feb 5, 2025 | Nancy A. Grygiel SVP & CCO | AMGN Amgen Inc. | Sale | 1,589 | $304.47 | $483.8K Sale | Form 4 ↗ |
25 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:59 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances